JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M503587200 on September 6, 2005

J. Biol. Chem., Vol. 280, Issue 45, 37319-37330, November 11, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/45/37319    most recent
M503587200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verlinden, L.
Right arrow Articles by Verstuyf, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verlinden, L.
Right arrow Articles by Verstuyf, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Characterization of the Condensin Component Cnap1 and Protein Kinase Melk as Novel E2F Target Genes Down-regulated by 1,25-Dihydroxyvitamin D3*

Lieve Verlinden{ddagger}1, Guy Eelen{ddagger}1, Ine Beullens{ddagger}, Mark Van Camp{ddagger}, Paul Van Hummelen§, Kristof Engelen¶, Ruth Van Hellemont¶, Kathleen Marchal¶, Bart De Moor¶, Floris Foijer||, Hein Te Riele||, Monique Beullens**, Mathieu Bollen**, Chantal Mathieu{ddagger}, Roger Bouillon{ddagger}2, and Annemieke Verstuyf{ddagger}

From the {ddagger}Laboratorium voor Experimentele Geneeskunde en Endocrinologie, Katholieke Universiteit Leuven, 3000 Leuven, Belgium, §MicroArray Facility, Vlaams Interuniversitair Instituut voor Biotechnologie (VIB), 3000 Leuven, Belgium, ESAT-SCD, Katholieke Universiteit Leuven, 3000 Leuven, Belgium, **Afdeling Biochemie, Katholieke Universiteit Leuven, Leuven, Belgium, and ||The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands

1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) has potent antiproliferative effects characterized by a hampered G1/S transition. cDNA microarrays were used to monitor expression of 21,492 genes in MC3T3-E1 mouse osteoblasts at 1, 6, 12, 24, and 36 h after treatment with 1,25(OH)2D3. Statistical analysis revealed a cluster of genes that were strongly down-regulated by 1,25(OH)2D3 and which not only function in cell cycle regulation and DNA replication but also mediate checkpoint control, DNA repair, chromosome modifications, and mitosis. Because many of these genes were shown earlier to be regulated by the transcriptional repressor E2F4, the intergenic regions of these 1,25(OH)2D3-down-regulated genes were searched for the presence of E2F binding sites. This led to the characterization of two novel E2F target genes, chromosome condensation-related SMC-associated protein 1 (Cnap1) and maternal embryonic leucine zipper kinase (Melk). Transfection studies and site-directed mutagenesis confirmed Cnap1 and Melk to be bona fide E2F targets. Repression of Cnap1 and Melk by 1,25(OH)2D3 was confirmed not only in MC3T3-E1 cells but also in several other bone-unrelated cell types. This down-regulation as well as the antiproliferative effect of 1,25(OH)2D3 depended on the pocket proteins p107 and p130 because 1,25(OH)2D3 failed to repress these E2F target genes and lost its antiproliferative action in p107–/–;p130–/– cells but not in pRb–/– cells.


Received for publication, April 1, 2005 , and in revised form, July 27, 2005.

* This work was supported by Fund for Scientific Research Grants FWO-G.0508.05 and FWO-G.0150.02). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Post-doctoral fellows of the Fund for Scientific Research and equal contributors to this work.

2 To whom correspondence should be addressed. Tel.: 32-16-345970; Fax: 32-16-345934; E-mail: Roger.Bouillon{at}med.kuleuven.be.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
J. J. Molenaar, M. E. Ebus, J. Koster, P. v. Sluis, C. J.M. van Noesel, R. Versteeg, and H. N. Caron
Cyclin D1 and CDK4 Activity Contribute to the Undifferentiated Phenotype in Neuroblastoma
Cancer Res., April 15, 2008; 68(8): 2599 - 2609.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Peng, R. Mehta, S. Wang, S. Chellappan, and R. G. Mehta
Prohibitin is a novel target gene of vitamin d involved in its antiproliferative action in breast cancer cells.
Cancer Res., July 15, 2006; 66(14): 7361 - 7369.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.